Joel Grosz
Associate Director, Entyvio HCP Marketing
Takeda Pharmaceuticals, U.S.A., Inc.
The Industry Trend Prognosticator
Is it possible for someone to stay ahead of the fast-paced changes of the advertising industry for nearly two decades and counting? Very simply: yes. Joel Grosz has an uncanny ability to predict where the market is going and meet it there. Does he have a crystal ball? Nah—his keen sense of what’s coming results from his tremendous ability to learn from yesterday to anticipate tomorrow.
Over the span of his career, Joel has built an impressive pedigree that includes a long tenure at CDM New York and stops at Ogilvy Health, FCB Health, and TBWA. At each agency, Joel developed critical skills that gave rise to a sixth sense for what the market needed, long before the market had any idea.
In January 2021, Joel brought this treasure trove of knowledge and insight to Takeda Pharmaceuticals. After years of creating materials for the field, Joel knows first-hand the value of the field sales team and partners with them to develop the necessary tools to respond to the ever-changing conditions on the ground. Joel understands the challenges and opportunities of the hybrid selling model that continues to evolve in these “after times.” With the support of colleagues and agency partners, he provides the sales team with the tools they need to engage with their customers in whichever platform they prefer.
In a world of fast-paced change and instability, Joel recognizes one critical constant: the need for a patient-centric approach. By putting the patient at the center, Joel is able to provide comprehensive resources for healthcare providers and their patients. His knowledge and experience directly contribute to their ability to identify appropriate patients who could benefit from Entyvio® (vedolizumab).
Beyond the creation of communication assets, Joel has used his agency experience to realize a new way of working at Takeda. He actively breaks down silos by fostering cross-team integration, using collaboration as the linchpin of success.
